通过抑制JAK/STAT通路,CD3D沉默可以缓解糖尿病病
Xianghong Lei1, Fangqin Zou1, Xianhu Tang1
1Department of Nephrology, the First Affiliated Hospital of Gannan Medical University, Ganzhou City, China.
概括
沉默CD3D通过减少损伤,炎症和脂质积累来改善糖尿病病 (DN). 这表明CD3D是DN治疗的潜在治疗标.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 糖尿病病 (DN) 是一种主要的糖尿病并发症,具有显著的全球健康影响.
- 了解驱动DN进展的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 阐明CD3D在糖尿病病进展中的功能作用和潜在机制.
- 评估CD3D抑制在DN中的治疗潜力.
主要方法:
- 对基因表达数据集 (GSE47183,GSE30528) 的生物信息分析,以确定关键基因.
- 在体内研究中,使用糖尿病病 (DN) 的小鼠进行CD3D沉默.
- 在高葡萄糖 (HG) 条件下使用HK-2细胞进行体外研究,并进行CD3D淘汰.
- 使用RO8191.1,对JAK/STAT路径进行调查.
主要成果:
- CD3D被确定为DN脏组织中调高的关键基因.
- 在DN小鼠中的CD3D沉默减少了损伤,炎症和脂质积累.
- 在HG治疗的HK-2细胞中,CD3D倒置改善了细胞活力,减少了细胞亡,并使脂质代谢正常化.
- CD3D下调抑制了JAK/STAT通路,减轻了HG诱导的细胞损伤.
结论:
- CD3D在糖尿病病变的发病过程中起着至关重要的作用.
- 通过缓解DN相关的病理,CD3D沉默显示了治疗潜力.
- 针对CD3D,可能通过JAK/STAT途径,为DN治疗提供了一个有希望的策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
346
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.7K
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:23Dipeptidyl Peptidase 4 Inhibitors
172
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
172
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K